The headline above is borrowed verbatim from a Feb. 6 Scientific American article (coverage here) after the House of Commons voted by 75 percent to make Britain the first nation to legalize “three-parent babies.” The House of Lords gave the final approval Feb. 24.  Newcastle University researchers are already paying women to be genetic donors, and the first such births are expected next year.

The hope here is to avoid babies with devastating “mitochondrial” birth defects and related ailments like muscular dystrophy.  So these experiments have the best of motives, though scientists and theologians alike question the means.  Reporters should note good online coverage of pros and cons by Sarah Knapton in the London Telegraph.

News media take note: The U.S. debate will gain prominence with a March 31 – April 1  “public workshop” in Washington by the  panel that’s advising the Food and Drug Administration (FDA) and Institute of Medicine on this. Its delightfully bureaucratic name: “Committee on Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases.”